Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

SODIUM CHLORIDE INJECT

Closed
SPE2DP-26-T-4162Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 17 days
NAICS: 325412
New
Federal
6505--FY27 Lenalidomide BPA
Solicitation # 36C26227Q0083
The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 12 days

AI Contract Overview

Show more

Sodium Chloride Injection 0.9% in 100 mL within a 150 mL fill plastic container, sold in packs of 64 units per PG, is being procured under solicitation SPE2DP-26-T-4162 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. The contract requires delivery of two PG units, equivalent to 128 units total, to Fort Bragg, North Carolina, with a delivery window of 20 days after order placement and FOB destination terms, meaning title and risk transfer to the government upon arrival at the delivery point. The product is regulated by the FDA and subject to a non-extendable shelf life of 15 months from manufacture, with expiration or retest dates clearly marked per requirements. Packaging and marking must conform to Medical Marking Standard No. 1A (dated February 4, 2013), superseding MIL-STD-129, with each unit sealed in a protective container and shipped in commercial exterior packaging suitable for safe carrier transport at the lowest rate. Labels must include NSN, manufacturer name, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number. Packaging and preservation must comply with MIL-STD-2073-1E under instruction MPWNN00001. The manufacturer is B. Braun Medical Inc with NDC code 00264-1800-32 and part number S8004-5264. Technical and quality specifications are governed by the DLA Master List, and compliance with hazard communication standards under OSHA 29 CFR 1910.1200 and DFARS clauses including 252.223-7001, 252.223-7006, and 252.223-7008 is mandatory. Inspection and acceptance occur at destination, with zero variance allowed in quantity. Invoicing must be submitted electronically via Wide Area WorkFlow, and payment is processed through designated DoDAACs. The solicitation incorporates FAR and DFARS clauses covering small business representation, employment eligibility, trafficking in persons, sustainable products, cybersecurity safeguards, export controls, hazardous material handling, and prohibition on certain telecommunications equipment. No evaluation factors or weights are formally stated, but award is expected under a lowest price technically acceptable approach given the nature

General Info

B. Braun delivers 128 units of 0.9% sodium chloride injection to Fort Bragg within 20 days under strict labeling and packaging standards.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
SODIUM CHLORIDE INJECTION
SODIUM CHLORIDE INJECTION
0.9%, 100 ML IN 150 ML FILL PLASTIC CONTAINER 64'S
. U/I "PG" (64'S)
Avoid excessive heat. Store at room temperature (25°C. RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 64 EA
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013. LABELS SHALL INCLUDE: NSN MANUFACTURER AND
CAGE DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE CONTRACT NUMBER/LOT
NUMBER.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS012: Shelf-life requirement RS001 for a TYPE I (CODE J) item with a
SPE2DP-26-T-4162
SECTION B
shelf life of 15 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N NDC00264-1800-32 B. BRAUN MEDICAL INC 11171 P/N S8004-5264
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017505622 0001 PG 2.000
NSN/MATERIAL:6505013308924
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-8924 Quantity: 2 PG Purchase Request: 7017505622QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS